The article “Dutasteride: A Review of Current Data on a Novel Dual Inhibitor of 5α Reductase” by Sibylle Marihart, MD, Mike Harik, MD, and Bob Djavan, MD, PhD, published in the Fall 2005 issue of Reviews in Urology,1 is virtually identical to an article published in Expert Opinions in Pharmacotherapy in February 2005.2
Footnotes
In Reply: I offer sincere apologies to the readers of Reviews in Urology. I did not understand that my two manuscripts would be considered duplicate at the time I submitted them. I thought that since the two journals had different readership that some overlap in wording would be acceptable.
References
- 1.Marihart S, Harik M, Djavan B. Dutasteride: a review of current data on a novel dual inhibitor of 5α reductase. Rev Urol. 2005;7(4):203–210. [PMC free article] [PubMed] [Google Scholar]
- 2.Djavan B, Milani S, Fong YK. Dutasteride: a novel dual inhibitor of 5alpha-reductase for benign prostatic hyperplasia. Expert Opin Pharmacother. 2005;6:311–317. doi: 10.1517/14656566.6.2.311. [DOI] [PubMed] [Google Scholar]